Dhoot Transmission vs Molbio Diagnostics: Surge in Mega-IPOs Forces Investors to Pick a Sector Bet
The Indian mainboard IPO market is experiencing a flurry of activity after a quiet period, with five diverse companies planning to go public. These offerings present investors with distinct bets across multiple sectors, including automotive components, diagnostics, dairy products, e-commerce logistics, and engineering. The combined issue size for these IPOs totals ₹7,479 crore by August 12.A Look at the Five Major IPO Offers
The companies offer a varied basket of investment opportunities, tailored to different risk appetites and sector preferences. Dhoot Transmission and Molbio Diagnostics open on August 10, while Milky Mist Dairy Food begins its subscription period on August 11. Shiprocket and Behari Lal Engineering follow suit on August 12.Dhoot Transmission leads the pack in size, aiming to raise ₹3,066.89 crore with a price band ranging from Rs 829-871 per share. The offering includes a fresh issue of ₹1,400 crore and an offer for sale component amounting to ₹1,666.89 crore. Molbio Diagnostics seeks to raise ₹940 crore at a price band of Rs 768-807 per share.
Milky Mist Dairy Food is offering ₹1,553 crore, priced between Rs 133-140 per share. This issue includes fresh capital of ₹1,428 crore and an offer for sale component totaling ₹125 crore. Shiprocket’s digital venture aims to raise ₹1,617 crore with a price band set at Rs 92-97 per share.
Deep Dive into the Auto and Health Sector Plays
Analysts are heavily focused on Dhoot Transmission and Molbio Diagnostics, seeing them as key plays for structural growth in their respective sectors. Dhoot is positioning itself directly within India’s automotive electrification cycle and holds market leadership in wiring harnesses.Antu Eapen Thomas of Geojit Investments favors Dhoot Transmission, noting that the company is well-placed to capitalize on future shifts in auto manufacturing. He highlighted that the IPO proceeds will be used for capacity expansion and debt reduction, strengthening the long-term growth outlook.
Moltbio Diagnostics represents a technology-forward healthcare investment opportunity. The company operates within research, development, and commercialization of rapid diagnostic solutions. Rahul Sharma of Equity99 sees Molbio as his top pick due to its proprietary Truenat platform—a portable, battery-operated PCR-based molecular diagnostics system.
Moltbio has secured 16 registered patents across its point-of-care micro-PCR platform, creating significant barriers against traditional diagnostic laboratories. Its financial performance includes a reported ROE of 15.59% and ROCE of 17.55%.
The Consumption and Digital Commerce Bets
Milky Mist Dairy Food offers investors a more stable consumption story within the group. The company operates in branded dairy and value-added food products, catering to steady household demand across India’s expanding food market. However, the possibility of an expensive valuation may impact near-term momentum for the stock.Shiprocket is structured as the digital commerce bet, operating as a merchant-first, AI-powered enablement platform. Its success hinges on the trajectory of India’s online commerce and the increasing needs of small and medium merchants for logistics solutions. The primary risk, according to analysts, lies in its path to profitability amid increased competitive pressure.
Behari Lal Engineering is noted as the smallest mainboard IPO in this set, aiming to raise ₹301.62 crore with a price band of Rs 271-285 per share. This issue offers niche engineering plays but currently receives less analyst focus compared to Dhoot and Molbio.
Analyst Verdict: Which IPO Holds the Most Promise?
When forced to choose, analysts provide nuanced guidance based on risk tolerance and growth appetite. For those seeking a balanced choice with strong sector tailwinds, Dhoot Transmission stands out due to its valuation comfort and use of proceeds for expansion.Moltbio Diagnostics is suited for investors willing to pay a premium valuation in exchange for proprietary healthcare technology and rapid revenue acceleration. Milky Mist suits the consumer-oriented investor prioritizing predictable demand. Shiprocket represents a longer-term digital commerce bet that carries inherent execution risk.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.